4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-040559
EVP, Global Head RA & Quality sold 3,346 shares at an average $1.65 ($5,531)
From the SEC's structured data for this filing
Trades in this filing
Henrich Jill · EVP, Global Head RA & Quality
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-16 | Sale : show line 1 in the form | −2,788 | $1.65 | $4,609 | 108,249 | D |
| 2023-08-16 | Sale : show line 2 in the form | −558 | $1.65 | $923 | 107,691 | D |
| Open-market sales · 3,346 sh · avg $1.65 · $5,531 | ||||||
Loading xslF345X05/form4.xml…